NASA has certified SpaceX’s Falcon 9 to launch the agency’s most important science missions, giving the agency new options that could result in lower costs.
SpaceX said that the NASA Launch Services Program (LSP) awarded its Category 3 certification for the company’s Falcon 9 rocket. That certification allows NASA to use the Falcon 9 for its highest-value science missions.
“LSP Category 3 certification is a major achievement for the Falcon 9 team and represents another key milestone in our close partnership with NASA,” Gwynne Shotwell, president of SpaceX, said in a statement. “We are honored to have the opportunity to provide cost-effective and reliable launch services to the country’s most critical scientific payloads.”
The Category 3 classification requires a vehicle to have performed at least 3, and as many as 14, successful launches. The difference in number of launches depends on the amount of additional NASA audits and reviews of the vehicle are performed to verify its reliability; more reviews allow NASA to certify the vehicle with a fewer number of launches. SpaceX did not specify what approach it used with NASA to obtain the Category 3 certification.
The current version of the Falcon 9, the Block 5, has performed six launches to date, all successfully. The overall Falcon 9 family has carried out more than 60 launches dating back to 2010, with one in-flight failure on a Dragon cargo mission in 2015 and a pad explosion in 2016 during preparations for a pre-launch static-fire test. There have been 34 consecutive successful Falcon 9 launches since that 2016 explosion.
Image Credit: NASA KSC/Tony Gray
News This Week
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations [...]
Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the body into a virus-zapping vaccine [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists from the University of Houston [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong focus for this year’s top 10 [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek at the data on its [...]
The first coronavirus vaccine can prevent more than 90% of people from getting Covid-19, a preliminary analysis shows. The developers - Pfizer and BioNTech - described it as a "great day for science and humanity". [...]
Researchers led by the University at Buffalo (UB) have devised a new method that could enhance the effectiveness of vaccines against the novel coronavirus, the virus that is responsible for causing COVID-19. Jonathan F. Lovell, PhD, an [...]
On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and felt tired but, after three [...]
One of the world’s leading Covid-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say, raising hopes of protection for those most vulnerable to the coronavirus that [...]
Coronavirus tests performed in labs are the gold standard for accuracy and antigen tests are a fast and inexpensive alternative. But backers of a third type of test, developed by a Nobel Prize winner [...]
COVID-19 is a severe infectious disease that has claimed >150,000 lives and infected millions in the United States thus far, especially the elderly population. Emerging evidence has shown the virus to cause hemorrhagic and immunologic [...]
Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves. “We estimate that the capacity limit [...]
Scientists are to increase surveillance for new coronavirus mutations amid concerns that future strains of the virus could develop at least partial resistance to antibody treatments and Covid-19 vaccines. There is no evidence that the [...]